🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In the treatment of pneumococcal diseases, the common use of penicillin-bas...
Status
Completed
Location
Jiangsu Provincial Center for Diseases Control and Prevention
Start Date
2023-11-18
Trial ID
NCT07025876
Treatments Being Tested
The purpose of this observer-blind study is to evaluate the safety, reactog...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-09-19
Trial ID
NCT00756067
Treatments Being Tested
This study is designed to explore the safety and tolerability of an investi...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01446926
Treatments Being Tested
The purpose of this study is to evaluate the safety, reactogenicity and imm...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-06-30
Trial ID
NCT00707798
Treatments Being Tested
Primary objectives: * To assess the safety profile of each SP0202 formulat...
Status
Completed
Location
The Children's Clinic Of Jonesboro PA Site Number : 8400143
Start Date
2020-05-22
Trial ID
NCT04398706
Treatments Being Tested
The objectives of this first-in-human study is to evaluate the tolerability...
Status
Unknown
Location
Velocity (Meridian) Clinical Research
Start Date
2023-03-07
Trial ID
NCT06337643
Treatments Being Tested
Phase I clinical trial of 24-valent pneumococcal conjugate vaccine (PCV24) ...
Status
Completed
Location
Zhenjiang Center for Disease Control and Prevention
Start Date
2023-11-19
Trial ID
NCT06678607
Treatments Being Tested
This study was aimed to explore safety and immunogenicity of two formulatio...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00381615
The purpose of this study is to examine the safety, reactogenicity and immu...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-10
Trial ID
NCT01767402
Treatments Being Tested
This study is designed to evaluate the safety, tolerability, and immunogeni...
Status
Completed
Location
Multiple Locations
Start Date
2010-02
Trial ID
NCT01444339